ICRA LTD. - 532835 - Shareholding for the Period Ended December 31, 2019
ICRA Ltd has submitted to BSE the Shareholding Pattern for the Period Ended December 31, 2019. For more details, kindly Click here08-01-2020
ICRA LTD. - 532835 - Shareholding for the Period Ended December 31, 2019
ICRA Ltd has submitted to BSE the Shareholding Pattern for the Period Ended December 31, 2019. For more details, kindly Click hereCable TV bills set to fall by up to 14 per cent, new tariff changes to take effect from March 1: ICRA
Apart from reducing the price per channel to Rs 12 from the earlier Rs 19, the new tariff order puts a cap on the channel bundle discount at 33 per centICRA Ltd - 532835 - Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations, 2018
Certificate pursuant to regulation 74(5) of the Securities and Exchange Board of India (Depositories and Participants) Regulations, 2018ICRA LTD. - 532835 - Statement Of Investor Complaints For The Quarter Ended December 2019
No.of Investor complaints pending at the beginning of the quarter No.of Investor complaints received during the quarter No.of Investor complaints disposed of during the quarter No.of Investor complaints unresolved at the end of the quarter 0770 Name of the Signatory :- S Shakeb RahmanDesignation :- Company Secretary and Compliance OfficerICRA maintains negative outlook on passenger vehicle, CV
There was a sharp divergence in retail demand growth and wholesale despatches during the first half of FY20 as focus was towards reducing inventory level, Icra said.ICRA maintains cautious stance on road sector
Ratings agency ICRA has maintained a cautious stance on the road sector, even as the government has decided to invest Rs 102 lakh crore from fiscal 20ICRA Ltd - 532835 - Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Intimation
Disclosure under Regulation 30 of the the Securities and Exchange Board of India (Listing Obligations and Disclosure Requirements) Regulations, 2015Year in review: In 2019, Indian pharma battled regulatory scare, and won
On the whole, rating agency ICRA maintained a stable outlook on the Indian pharmaceutical industryICRA Ltd - 532835 - Disclosure Under Regulation 30 Of The SEBI (Listing Obligations And Disclosure Requirements) Regulations, 2015
Disclosure under regulation 30 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, regarding adjudication order/SS/AS/2019-20/6280